在心脏手术后显著增加高灵敏度热素和住院死亡率
Pavan Reddy1, Matteo Cellamare1, Ilan Merdler1
1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
概括
心脏手术后显著增加的高灵敏性热血素 (hsTnI) 与增加住院死亡风险有关. 这一发现可以帮助指导手术后立即的患者管理.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 生物标志物 生物标志物
背景情况:
- 高灵敏度热素 (hsTnI) 是已知的心脏死亡预测因子.
- 关于显著升高的hsTnI和心脏手术后住院死亡率的数据有限.
- 了解这种关系可以优化急性术后管理.
研究的目的:
- 确定显著升高的hsTnI与心脏手术后住院死亡率之间的关系.
- 确定hsTnI作为潜在的风险分层工具在手术后期.
主要方法:
- 从2020年1月到2022年6月的心脏手术的回顾性分析.
- 包括标准:峰值hsTnI>35x正常的上限 (ULN=34 ng/L).
- 主要结局:住院死亡率. 对CABG与其他心脏手术的子组分析.
主要成果:
- 分析了1382例病例;平均年龄为64.8岁,68.2%为男性.
- 平均高峰血压为4202 ng/L.
- 每增加1000 ng/L hsTnI与住院死亡几率上升3.8%相关 (OR1.038,p<0.0001).
- 多变量分析证实了hsTnI与死亡率的显著关联 (OR1.02,p=0.004).
- 在高达60,000 ng/L的hsTnI水平下,CABG显示死亡风险低于其他手术.
结论:
- 增加hsTnI水平与更高的住院死亡概率显著相关.
- 升高的hsTnI是指导医院内临床管理的客观风险指标.
- hsTnI可以帮助及时干预和对高风险心脏手术后患者的资源分配.
更多相关视频
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
8.1K
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.3K
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
141
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
141
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
80
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
80
